| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |